Hexagon Nutrition has scheduled its 33rd Annual General Meeting for September 22, 2026, alongside reporting its strongest-ever financial performance for FY2025-26, with consolidated profit after tax rising 56% year-on-year to ₹379.37 million.

FY26 Financial Highlights

The company's consolidated revenue from operations grew 17.8% year-on-year to ₹3,826.28 million in FY2025-26, compared to ₹3,249.29 million in FY2024-25. Profitability expanded well ahead of revenue, with EBITDA rising 32.0% to ₹529 million and EBITDA margin widening to 13.8% from 12.3% in the prior year. PAT margin improved to 9.9% from 7.5%.

On a standalone basis, revenue from operations stood at ₹3,191.20 million versus ₹2,674.47 million in FY2024-25, with standalone PAT at ₹381.48 million compared to ₹269.69 million.

Segment Performance

The company operates across three segments. The branded nutrition (B2C) segment delivered year-on-year growth of 23.74%, crossing the ₹1,000 million mark. The premix formulations (B2B2C) segment grew 31% overall, with domestic premix up 44.06% and export premix up 24.87%. The ESG segment declined 16.51% due to delays in tender releases.

Export revenue contributed approximately 57% of total FY26 revenue, with the company exporting to 80+ countries across five continents.

IPO Listing and Corporate Developments

Hexagon Nutrition listed on the NSE and BSE on June 12, 2026, through a 100% Offer for Sale of 3,08,59,704 equity shares at an issue price of ₹45 per share, aggregating to ₹138.87 crore. The IPO was subscribed 53.68 times overall, with the QIB portion subscribed 19.77 times, NII 161.49 times, and retail 26.85 times. The listing price was ₹48.25 per share on NSE and ₹48.00 per share on BSE.

During the year, Hexagon Nutrition (Exports) Private Limited was amalgamated with the company pursuant to an NCLT order dated January 14, 2026, with an appointed date of April 1, 2025.

Dividend and AGM Agenda

The Board has recommended a final dividend of ₹0.30 per equity share of face value ₹1 each for FY2025-26, subject to shareholder approval at the AGM. The record date for dividend eligibility is September 15, 2026, and the dividend payment date is between September 23, 2026 and October 22, 2026.

The 33rd AGM will be held on Tuesday, September 22, 2026 at 11:30 AM (IST) through video conferencing. Key resolutions include adoption of financial statements, re-appointment of Dr. Nikhil Arun Kelkar as Joint Managing Director, declaration of the final dividend, appointment of Raghunath Sawant as Executive Director, revision in remuneration of executive directors, and alteration of the Articles of Association.

Key Financial Ratios

The company's R&D expenditure for FY26 stood at ₹18.35 million. Foreign exchange inflows were ₹1,498.79 million and outflows were ₹660.91 million during the year.

Vikram Kelkar, Managing Director and promoter of Hexagon Nutrition , has increased his stake in the company by acquiring 16,300 equity shares. The transaction took place in the open market on August 17, 2026, resulting in a marginal rise in his overall holding percentage.

The acquisition brings Kelkar’s total shareholding to 2,59,61,344 shares, representing 21.12% of the company’s total voting capital. Prior to this transaction, he held 2,59,45,044 shares, which accounted for 21.11% of the voting capital. The company’s total equity share capital remained unchanged at 12,29,18,109 shares following the trade.

Transaction Details

The disclosure was submitted to the National Stock Exchange of India Limited and BSE Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The filing confirms that Kelkar belongs to the promoter group and that the shares were acquired via open market purchases rather than off-market transfers or preferential allotments.

There were no encumbrances, pledges, or liens reported on the acquired shares. Additionally, there were no changes in voting rights other than those carried by the equity shares, nor were any warrants or convertible securities involved in the transaction.

What the Numbers Show

The acquisition represents a minimal change in ownership structure, with Kelkar’s stake increasing by just 0.01 percentage points. This type of small-scale open market purchase is often indicative of routine portfolio adjustment or long-term confidence maintenance by promoters, rather than a strategic shift in control. The absence of any encumbrance on the newly acquired shares suggests these holdings are free for potential future use, though no immediate plans for pledging were disclosed.